Twist Bioscience Corp (TWST) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic ... [Yahoo! Finance]
Twist Bioscience Corporation (TWST)
Last twist bioscience corporation earnings: 2/6 04:05 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
Gross Margin: 51.3% for Q4; 50.7% for fiscal 2025, up from 42.6% in fiscal 2024. Sinbio Revenue: $39.5 million for Q4, a 17% increase year over year; $145 million for fiscal 2025, a 17% increase over fiscal 2024. NGS Revenue: $53 million for Q4, a 16% increase year over year; $208.1 million for fiscal 2025, a 23% increase over fiscal 2024. Biopharma Revenue: $6.4 million for Q4, a 22% increase year over year; $23.5 million for fiscal 2025, a 15% increase over fiscal 2024. Operating Expenses: $80.8 million for Q4; $327.3 million for fiscal 2025. Adjusted EBITDA: Loss of $7.8 million for Q4, an improvement of $9.2 million year over year; Loss of $46.9 million for fiscal 2025, an improvement of $46.6 million over fiscal 2024. Cash Flow from Operating Activities: Net cash used was $47.6 million for the 12 months ended September 30, 2025, compared to $64.1 million for the equivalent period in 2024. Capital Expenditures: $28 million for fiscal 2025. Cash Equivalents and Sho
Show less
Read more
Impact Snapshot
Event Time:
TWST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TWST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TWST alerts
High impacting Twist Bioscience Corporation news events
Weekly update
A roundup of the hottest topics
TWST
News
- Twist Bioscience (TWST): Valuation Check After New Research-Grade Plasmid DNA Preps Boost Investor Interest [Yahoo! Finance]Yahoo! Finance
- Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics ResearchBusiness Wire
- Kuehn Law Encourages Investors of Twist Bioscience Corporation to Contact Law FirmGlobeNewswire
- Twist Bioscience (NASDAQ:TWST) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Stephens Initiates Twist Bioscience (TWST) With Overweight Rating, Sets $41 PT [Yahoo! Finance]Yahoo! Finance
TWST
Earnings
- 11/14/25 - Miss
TWST
Sec Filings
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- 11/25/25 - Form 4
- TWST's page on the SEC website